Utilities, Consumer...
AMAG Pharmaceuticals Inc. (AMAG: NASDAQ)
$16.74 -0.16 | -0.95%
02/08/12 - 04:00 PM ET
54.76K / 179.90K
Vol / Avg. Vol:16.92 / 16.90
Open / Prev. Close:16.44 - 17.38
Today's Range:12.65 - 19.62
52 Wk Range:-11.48%
Performance YTD:TheStreet Rating:
Portfolios with AMAG
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- UserPelican Watch
- ProQVT Financial
- UserPART 1 JPMorgan 28th Annual...
- UserPART 1 JPMorgan 27th Annual...
- Userileana
- UserShawen Portfolio 1
- Userfiallo Portfolio 1
- UserTSimao Portfolio 1
- Usersggrimsley
Latest AMAG Headlines from TheStreet
- More Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- The Next Big Thing In Biotech: 2012 Outlook
01.06.12 | 05:01 am - 5 Stocks Poised for Breakouts 11.07.11 | 09:11 am
- Next Step for Amag's Board: Fire CEO, Sell the Company. 10.21.11 | 11:10 am
- Biotech Stock Mailbag: Keryx Pharma 10.14.11 | 06:10 am
- Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos 10.10.11 | 10:10 am
- Spectrum Pharma Said to Make Bid for Allos 09.21.11 | 11:09 am
- Biotech Stock Mailbag: Vivus 09.16.11 | 05:09 am
- Biotech Stock Live Chat 09.15.11 | 11:09 am
- Amag-Allos Merger in Jeopardy 09.07.11 | 06:09 am
Press Releases for AMAG
- AMAG Pharmaceuticals Announces The Appointment Of Two Independent Directors To Its Board - Business Wire 02.07.12 | 04:02 pm
- AMAG Pharmaceuticals Announces Completion Of Enrollment In Its Phase III Program Evaluating Feraheme For A Broader Iron Deficiency Anemia Indication - Business Wire 01.30.12 | 08:01 am
- AMAG Pharmaceuticals Provides Business Update - Business Wire 01.09.12 | 07:01 am
- AMAG Pharmaceuticals, Inc. To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.12 | 07:01 am
- AMAG Pharmaceuticals Announces Preliminary Data Regarding The Safety And Efficacy Of A Single Infusion Of 1020 Mg Ferumoxytol (Feraheme®) In Patients With Iron Deficiency Anemia - Business Wire 12.12.11 | 07:12 am
- AMAG Pharmaceuticals, Inc. To Present At The 23rd Annual Piper Jaffray Healthcare Conference - Business Wire 11.22.11 | 04:11 pm
- AMAG Pharmaceuticals Hires Financial Advisor As The Company Explores All Opportunities To Enhance Stockholder Value - Business Wire 11.17.11 | 08:11 am
- AMAG Pharmaceuticals, Inc. Announces Positive Data From The FIRST Trial, A Head-to-Head Comparison Trial Of Ferumoxytol (Feraheme®) Compared To Iron Sucrose - Business Wire 11.12.11 | 09:11 am
- AMAG Announces Financial Results For The Third Quarter Ended September 30, 2011 - Business Wire 11.04.11 | 07:11 am
- AMAG Pharmaceuticals Reschedules Third Quarter Financial Results Conference Call To November 4, 2011 At 8:00 A.m. ET - Business Wire 11.03.11 | 04:11 pm
Partner Headlines for AMAG
- Israel Englander's Stock Picks With Insider Purchases - Seeking Alpha 01.18.12 | 09:01 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
- McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23 - Benzinga 12.12.11 | 01:12 pm
- Mid-Day Update: Stocks Pare Some Early Losses; Unemployment Claims Lift Sentiment - NASDAQ 11.17.11 | 05:11 pm
- Loss Shrinks at AMAG, CEO Departs - Analyst Blog - Zacks 11.08.11 | 10:11 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.26.11 | 09:10 am
- Stocks Rally on European Debt Summit Optimism; December Crude Surges Over 2% - NASDAQ 10.21.11 | 04:10 pm
- Mid-Day Update: Stocks Surge, Indexes Top 1% on Europe Debt Optimism, Earnings - NASDAQ 10.21.11 | 04:10 pm
- End-of-Day Market Summary for October 21, 2011 - Benzinga 10.21.11 | 04:10 pm
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am






